19 January 2018
News and Views
Links and Services
Silymarin use reduces liver disease progression in the HALT-C trial, reports the recently published Alimentary Pharmacology & Therapeutics.
Silymarin is the most commonly used herbal product for chronic liver disease; yet, whether silyma
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors